What if rewriting our genetic code was no longer science fiction, but a real way to cure disease and slow aging?Join me at the Global Longevity Summit this October. Use code BEYONDTOMORROW for 10% off your ticket: https://informaconnect.com/global-longevity-summit/In this episode of The Beyond Tomorrow Podcast, we explore the frontier of cell and gene therapy with Yuta Lee and Matt Scholz. From CAR-T cancer treatments to the ethics of CRISPR babies and even reprogramming our bodies to stay biologically young, we dive into the breakthroughs and risks shaping the future of medicine.From the rise of CAR-T therapies that are revolutionizing cancer treatment, to the controversial topic of germline editing in embryos, to futuristic possibilities like reprogramming our bodies to resist radiation on Mars - this episode explores both the promises and perils of playing with the source code of life.If you care about longevity, innovation, or the future of human health, this conversation will expand what you think is possible.📌 What You’ll Learn in This Episode:The difference between cell therapy and gene therapy and why it mattersHow CAR-T therapies are changing the way we treat blood cancersThe ethical controversy around germline editing and “CRISPR babies”Why gene therapy may be the only path to meaningfully extending human lifespanThe risks, benefits, and real-world results of current clinical trialsHow reprogramming cells could one day keep our bodies biologically youngThe role of gene therapy in tackling aging, frailty, and chronic diseaseThe potential for biotech to democratize longevity and the trillion-dollar market it could createThe existential risks: engineered viruses, unintended consequences, and ethical dilemmasA glimpse into 2030 and beyond, what superhuman capabilities might actually be possible⏱ Timestamps0:00 – Why gene therapy could solve cancer in our lifetime3:53 – What gene therapy really is and why people fear it6:06 – The controversial story of the CRISPR babies7:18 – CAR-T therapies explained: reprogramming your immune system to fight cancer11:15 – Success rates, risks, and breakthroughs in CAR-T cancer treatments17:46 – Germline editing: ethical dilemmas and global restrictions23:01 – Gene therapy for space travel: designing DNA to resist radiation26:03 – COVID vaccines as the world’s first mass gene therapy39:00 – Would you take gene therapy for longevity or only for survival?44:48 – Senolytics: programming aging cells to self-destruct56:35 – The road to 2030: curing solid tumors and extending healthspan1:02:57 – Closing reflections: a paradigm shift in human health and longevity🎙 Hosted by Julian Issa📸 Instagram: @thebeyondtomorrowpodcast🌐 Website: www.beyondtomorrowpodcast.com📩 Email: [email protected]🎧 Subscribe on Spotify, Apple, and YouTube for more stories from the edge of what’s possible.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related